MNMD Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-03-14 | Greenway Schond L. | officer: Chief Financial Officer | 1,445,000 | A-Award | A | 175,000 | 0.00 | 0.00 |
| 2023-03-14 | Wernli Miri Halperin | director, officer: Executive President | 1,375,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2023-03-14 | Karlin Dan | officer: Chief Medical Officer | 385,505 | A-Award | A | 125,000 | 0.00 | 0.00 |
| 2023-03-14 | Liao Carrie | officer: VP, Controller&Acct Principal | 478,430 | A-Award | A | 75,000 | 0.00 | 0.00 |
| 2023-03-14 | Barrow Robert | director, officer: Chief Executive Officer | 638,959 | A-Award | A | 400,000 | 0.00 | 0.00 |
| 2023-03-01 | Barrow Robert | director, officer: Chief Executive Officer | 238,959 | S-Sale | D | 8,273 | 3.51 | 29,038.23 |
| 2023-03-01 | Karlin Dan | officer: Chief Medical Officer | 260,505 | S-Sale | D | 3,577 | 3.51 | 12,555.27 |
| 2022-12-21 | Barrow Robert | director, officer: Chief Executive Officer | 247,232 | S-Sale | D | 3,861 | 2.69 | 10,386.09 |
| 2022-12-21 | Karlin Dan | officer: Chief Medical Officer | 264,082 | S-Sale | D | 1,211 | 2.69 | 3,257.59 |
| 2022-10-27 | Karlin Dan | officer: Chief Medical Officer | 265,293 | S-Sale | D | 644 | 3.00 | 1,932.00 |
| 2022-10-25 | Karlin Dan | officer: Chief Medical Officer | 265,937 | S-Sale | D | 541 | 2.81 | 1,520.21 |
| 2022-10-25 | Barrow Robert | director, officer: Chief Executive Officer | 251,093 | S-Sale | D | 1,207 | 2.81 | 3,391.67 |
| 2022-10-18 | Barrow Robert | director, officer: Chief Executive Officer | 252,300 | S-Sale | D | 1,220 | 3.11 | 3,794.20 |
| 2022-09-27 | Karlin Dan | officer: Chief Medical Officer | 266,478 | S-Sale | D | 640 | 5.87 | 3,756.80 |
| 2022-09-26 | Karlin Dan | officer: Chief Medical Officer | 267,118 | S-Sale | D | 565 | 5.51 | 3,113.15 |
| 2022-09-26 | Barrow Robert | director, officer: Chief Executive Officer | 253,520 | S-Sale | D | 1,264 | 5.51 | 6,964.64 |
| 2022-09-16 | Barrow Robert | director, officer: Chief Executive Officer | 254,784 | S-Sale | D | 1,350 | 7.26 | 9,801.00 |
| 2022-08-31 | Karlin Dan | officer: Chief Medical Officer | 267,683 | S-Sale | D | 1,204 | 11.67 | 14,050.68 |
| 2022-08-31 | Barrow Robert | director, officer: Chief Executive Officer | 256,134 | S-Sale | D | 1,228 | 11.67 | 14,330.76 |
| 2022-08-16 | Barrow Robert | director, officer: Chief Executive Officer | 3,860,438 | S-Sale | D | 20,350 | 0.68 | 13,838.00 |
| 2022-08-11 | Bruhn Suzanne Louise | director | 503,773 | A-Award | A | 503,773 | 0.00 | 0.00 |
| 2022-08-11 | Bruhn Suzanne Louise | director | 120,968 | A-Award | A | 120,968 | 0.66 | 79,838.88 |
| 2022-08-11 | Bruhn Suzanne Louise | director | 89,286 | A-Award | A | 89,286 | 0.00 | 0.00 |
| 2022-08-11 | CRYSTAL ROGER | director | 503,773 | A-Award | A | 503,773 | 0.00 | 0.00 |
| 2022-08-11 | CRYSTAL ROGER | director | 120,968 | A-Award | A | 120,968 | 0.66 | 79,838.88 |
| 2022-08-11 | CRYSTAL ROGER | director | 89,286 | A-Award | A | 89,286 | 0.00 | 0.00 |
| 2022-07-27 | Karlin Dan | officer: Chief Medical Officer | 4,033,264 | S-Sale | D | 9,856 | 0.69 | 6,800.64 |
| 2022-07-25 | Karlin Dan | officer: Chief Medical Officer | 4,043,120 | S-Sale | D | 8,361 | 0.69 | 5,769.09 |
| 2022-07-25 | Barrow Robert | director, officer: Chief Executive Officer | 3,880,788 | S-Sale | D | 18,681 | 0.69 | 12,889.89 |
| 2022-07-18 | Barrow Robert | director, officer: Chief Executive Officer | 3,899,469 | S-Sale | D | 19,388 | 0.70 | 13,571.60 |
| 2022-06-27 | Barrow Robert | director, officer: Chief Executive Officer | 3,918,857 | S-Sale | D | 36,762 | 0.70 | 25,733.40 |
| 2022-06-27 | Karlin Dan | officer: Chief Medical Officer | 4,051,481 | S-Sale | D | 26,238 | 0.70 | 18,366.60 |
| 2022-06-16 | Barrow Robert | director, officer: Chief Executive Officer | 3,955,619 | S-Sale | D | 21,275 | 0.70 | 14,892.50 |
| 2022-06-01 | Vallone Carol A | director | 62,196 | A-Award | A | 34,353 | 0.00 | 0.00 |
| 2022-06-01 | Vallone Carol A | director | 802,516 | A-Award | A | 774,673 | 0.00 | 0.00 |
| 2022-06-01 | Vallone Carol A | director | 126,041 | A-Award | A | 98,198 | 0.00 | 0.00 |
| 2022-06-01 | Vallone Carol A | director | 161,587 | A-Award | A | 133,744 | 0.60 | 80,246.40 |
| 2022-06-01 | Vallone Carol A | director | 43,104 | A-Award | A | 43,104 | 0.00 | 0.00 |
| 2022-06-01 | Makes Brigid | director | 643,804 | A-Award | A | 361,680 | 0.00 | 0.00 |
| 2022-06-01 | Makes Brigid | director | 194,358 | A-Award | A | 100,308 | 0.60 | 60,184.80 |
| 2022-06-01 | Makes Brigid | director | 158,706 | A-Award | A | 64,656 | 0.00 | 0.00 |
| 2022-06-01 | Krebs Andreas | director | 68,392 | A-Award | A | 28,628 | 0.00 | 0.00 |
| 2022-06-01 | Krebs Andreas | director | 759,701 | A-Award | A | 717,937 | 0.00 | 0.00 |
| 2022-06-01 | Krebs Andreas | director | 139,962 | A-Award | A | 98,198 | 0.00 | 0.00 |
| 2022-06-01 | Krebs Andreas | director | 175,508 | A-Award | A | 133,744 | 0.60 | 80,246.40 |
| 2022-06-01 | Krebs Andreas | director | 21,552 | A-Award | A | 21,552 | 0.00 | 0.00 |
| 2022-05-27 | Karlin Dan | officer: Chief Medical Officer | 4,077,719 | S-Sale | D | 9,555 | 0.82 | 7,835.10 |
| 2022-05-25 | Karlin Dan | officer: Chief Medical Officer | 4,087,274 | S-Sale | D | 8,242 | 0.77 | 6,346.34 |
| 2022-05-25 | Barrow Robert | director, officer: Chief Executive Officer | 3,976,894 | S-Sale | D | 18,415 | 0.77 | 14,179.55 |
| 2022-05-23 | Greenway Schond L. | officer: Chief Financial Officer | 1,650,000 | A-Award | A | 1,650,000 | 0.78 | 1,287,000.00 |
| 2022-05-23 | Greenway Schond L. | officer: Chief Financial Officer | 1,270,000 | A-Award | A | 1,270,000 | 0.00 | 0.00 |
| 2022-05-18 | Barrow Robert | director, officer: Chief Executive Officer | 3,995,309 | S-Sale | D | 18,948 | 0.71 | 13,453.08 |
| 2022-05-15 | Barrow Robert | director, officer: Chief Executive Officer | 3,995,309 | F-InKind | D | 18,948 | 0.82 | 15,537.36 |
| 2022-05-11 | Makes Brigid | director | 94,050 | J-Other | A | 67,678 | 0.00 | 0.00 |
| 2022-04-26 | Karlin Dan | officer: Chief Medical Officer | 4,095,516 | F-InKind | D | 13,038 | 0.81 | 10,560.78 |
| 2022-04-18 | Barrow Robert | director, officer: Chief Executive Officer | 4,014,257 | F-InKind | D | 19,110 | 0.92 | 17,581.20 |
| 2022-03-28 | Karlin Dan | officer: Chief Medical Officer | 4,108,554 | F-InKind | D | 10,203 | 1.17 | 11,937.51 |
| 2022-03-24 | Hu Cynthia W. | officer: Chief Legal Officer&Secretary | 1,560,000 | A-Award | A | 1,560,000 | 1.18 | 1,840,800.00 |
| 2022-03-24 | Hu Cynthia W. | officer: Chief Legal Officer&Secretary | 1,200,000 | A-Award | A | 1,200,000 | 0.00 | 0.00 |
| 2022-03-24 | Wernli Miri Halperin | director, officer: Executive President | 4,462,500 | A-Award | A | 780,000 | 1.18 | 920,400.00 |
| 2022-03-24 | Wernli Miri Halperin | director, officer: Executive President | 1,275,000 | A-Award | A | 600,000 | 0.00 | 0.00 |
| 2022-03-24 | Karlin Dan | officer: Chief Medical Officer | 2,719,000 | A-Award | A | 1,250,000 | 1.18 | 1,475,000.00 |
| 2022-03-24 | Karlin Dan | officer: Chief Medical Officer | 4,118,757 | A-Award | A | 950,000 | 0.00 | 0.00 |
| 2022-03-24 | Barrow Robert | director, officer: Chief Executive Officer | 6,425,500 | A-Award | A | 2,910,000 | 1.18 | 3,433,800.00 |
| 2022-03-24 | Barrow Robert | director, officer: Chief Executive Officer | 4,033,367 | A-Award | A | 1,820,000 | 0.00 | 0.00 |
| 2022-03-15 | Barrow Robert | director, officer: Chief Executive Officer | 2,213,367 | F-InKind | D | 12,612 | 1.00 | 12,612.00 |
| 2022-02-26 | Karlin Dan | officer: Chief Medical Officer | 3,168,757 | F-InKind | D | 118,143 | 1.21 | 142,953.03 |
| 2022-02-15 | Barrow Robert | director, officer: Chief Executive Officer | 2,225,979 | F-InKind | D | 18,734 | 1.35 | 25,290.90 |
| 2022-02-10 | Liao Carrie | officer: VP, Controller&Acct Principal | 524,450 | A-Award | A | 524,450 | 1.34 | 702,763.00 |
| 2022-02-10 | Liao Carrie | officer: VP, Controller&Acct Principal | 403,430 | A-Award | A | 403,430 | 0.00 | 0.00 |
| 2022-01-15 | Barrow Robert | director, officer: Chief Executive Officer | 2,244,713 | F-InKind | D | 190,287 | 1.05 | 199,801.35 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.